The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.50
Bid: 316.00
Ask: 317.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.316%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 314.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Mar 2014 16:15

RNS Number : 3970B
Morgan Advanced Materials PLC
03 March 2014
 



Notification of interests of directors/persons discharging managerial responsibility and connected persons ("PDMRs")

3 March 2014

This notification is made pursuant to DTR 3.1.4R(1)(a).

The Company announces that on 28 February 2014 awards over ordinary 25p shares in the Company were made to the Directors and PDMRs listed below under the Company's Long-Term Incentive Plan 2004 (LTIP), including the HMRC approved Schedule.

The awards under the LTIP comprise up to three elements, (i) and (iii) relate to certain UK participants: (i) an HM Revenue & Customs approved option over shares up to the value of £30,000 with an exercise price of 338.34 pence per share; (ii) an LTIP award in the form of a conditional award of free shares to the value of the remainder of the award; and (iii) a funding award, also in the form of a conditional award of free shares, over such number of shares whose value at exercise of the approved option equals the value of the approved option on award.

Subject to satisfaction of performance targets, awards under the LTIP will vest in three years' time.

In addition to the satisfaction of the performance targets, the approved option will only vest in the event that the market value of a share at vesting is greater than 338.34 pence per share. The funding award is used to fund the exercise price of the approved option and will be satisfied by shares from the Company's employee benefit trust.

Name

Number of shares subject to award (LTIP award and approved option, where applicable)

 

Maximum number of shares subject to funding award (not retained by participant)

Mark Robertshaw (Director)

166,697 LTIP

8,866 Approved Option

8,866

Kevin Dangerfield (Director)

81,436 LTIP

7,232 Approved Option

7,232

Andrew Hosty (Director)

93,101

0

Peter Blausten (PDMR)

20,690 LTIP

8,866 Approved Option

8,866

Paul Boulton (PDMR)

29,556

0

Ralph Gomarsall (PDMR)

8,866

0

Bill Grab (PDMR)

22,167

0

Simon Halliday (PDMR)

29,556

0

Andrew Riley (PDMR)

29,556

0

Ian Robb (PDMR)

36,945

0

John Stang (PDMR)

36,945

0

 

Following the grant of awards detailed above, the total number of shares in respect of which awards are held by those individuals pursuant to the Company's LTIP are detailed below:

Name

Total number of shares held pursuant to LTIP awards

Mark Robertshaw

482,476

Kevin Dangerfield

270,897

Andrew Hosty

292,914

Peter Blausten

93,495

Paul Boulton

93,495

Ralph Gomarsall

28,047

Bill Grab

48,515

Simon Halliday

87,102

Andrew Riley

93,495

Ian Robb

95,263

John Stang

81,210

 

 

Enquiries: Stephanie Mackie, Morgan Advanced Materials plc

 

Tel: 01753 837000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLRVVIVIIS
Date   Source Headline
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.